BRAINSTORM CELL THERAPEUTICS

CUSIP: 10501E201 Class: COM NEW

Ikarian Capital, LLC's Holding History (CIK: 0001778253)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 90,242 Value ($000) $31 Avg Close — Range —
Q1 2024
Shares 90,242 Value ($000) $51 Avg Close — Range —
Q4 2023
Shares 90,242 Value ($000) $25 Avg Close — Range —
Q3 2023
Shares 90,242 Value ($000) $18 Avg Close — Range —
Q2 2023
Shares 189,935 Value ($000) $391 Avg Close — Range —
Q1 2023
Shares 189,935 Value ($000) $627 Avg Close — Range —
Q4 2022
Shares 189,935 Value ($000) $311 Avg Close — Range —
Q3 2022
Shares 189,935 Value ($000) $839 Avg Close — Range —
Q2 2022
Shares 253,432 Value ($000) $698 Avg Close — Range —
Q1 2022
Shares 304,161 Value ($000) $1,022 Avg Close — Range —
Q4 2021
Shares 289,550 Value ($000) $1,159 Avg Close — Range —
Q3 2021
Shares 289,550 Value ($000) $955 Avg Close — Range —
Q2 2021
Shares 293,200 Value ($000) $1,115 Avg Close — Range —
Q1 2021
Shares 293,200 Value ($000) $1,122 Avg Close — Range —